Tien P. Wong, MD

Assistant Professor of Clinical Ophthalmology, Academic Institute
Houston Methodist
Weill Cornell Medical College


Education & Training

MD, Baylor College of Medicine
Internship, Baylor College of Medicine
Clinical Fellowship, Wills Eye Institute
Residency, Wills Eye Institute
Publications

Prostaglandin-Induced Macular Hole: A Brief Report
Alsoudi, AF, Anderson, JT, Wong, TP & Schefler, AC 2024, , Ophthalmic Surgery Lasers and Imaging Retina, vol. 55, no. 2, pp. 112-115. https://doi.org/10.3928/23258160-20231205-01

USE OF OPTICAL COHERENCE TOMOGRAPHY IN DETECTING RETINAL TEARS IN ACUTE, SYMPTOMATIC POSTERIOR VITREOUS DETACHMENT
Rao, AV, Shah, AR, Nguyen, VT, Pearce, W, Wong, TP, Brown, DM, Wykoff, CC & Patel, SB 2023, , Retina, vol. 43, no. 5, pp. 802-807. https://doi.org/10.1097/IAE.0000000000003718

Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group 2023, , Ophthalmology Retina, vol. 7, no. 7, pp. 564-572. https://doi.org/10.1016/j.oret.2023.02.008

Impact of Race and Ethnicity on Presentation and Surgical Outcomes of Idiopathic Macular Holes
Parvus, MN, Louis, AM, Trejo Corona, S, Wong, TP, Major, JC, Patel, SB & Wykoff, CC 2022, , Journal of Personalized Medicine, vol. 12, no. 9, 1518. https://doi.org/10.3390/jpm12091518

Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group 2022, , Ophthalmology Retina, vol. 6, no. 9, pp. 771-785. https://doi.org/10.1016/j.oret.2022.03.024

Favorable Anti-VEGF Crunch Syndrome: Nonsurgical Relief of Vitreoretinal Traction in Eyes with Proliferative Diabetic Retinopathy and Tractional Retinal Detachment
Lee, IT, Corona, ST, Wong, TP, Flynn, HW & Wykoff, CC 2022, , Ophthalmic Surgery Lasers and Imaging Retina, vol. 53, no. 8, pp. 455-459. https://doi.org/10.3928/23258160-20220628-01

Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
RECOVERY Study Group 2022, , Ophthalmology Retina, vol. 6, no. 7, pp. 557-566. https://doi.org/10.1016/j.oret.2022.02.013

Outcomes of Eyes Undergoing Multiple Surgical Interventions after Failure of Primary Rhegmatogenous Retinal Detachment Repair
Stenz, EC, Yu, HJ, Shah, AR, Wong, TP, Major, JC, Benz, MS, Wykoff, CC & Patel, SB 2022, , Ophthalmology Retina, vol. 6, no. 5, pp. 339-346. https://doi.org/10.1016/j.oret.2022.01.007

COMPARISON OF 25- AND 27-GAUGE SUTURELESS CANNULA-BASED INTRAOCULAR LENS SCLERAL FIXATION VISUAL ACUITY OUTCOMES AND COMPLICATION RATES
Kadakia, AB, Wong, TP, Wykoff, CC & Shah, AR 2021, , Retina, vol. 41, no. 5, pp. 940-946. https://doi.org/10.1097/IAE.0000000000002991

THE TEXAS TACO TECHNIQUE FOR INTERNAL LIMITING MEMBRANE FLAP IN LARGE FULL-THICKNESS MACULAR HOLES: A Short-Term Pilot Study
Major, JC, Lampen, SIR, Wykoff, CC, Ou, WC, Brown, DM, Wong, TP & Shah, AR 2020, , Retina (Philadelphia, Pa.), vol. 40, no. 3, pp. 552-556. https://doi.org/10.1097/IAE.0000000000002431

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Study Group 2019, , Ophthalmology Retina, vol. 3, no. 12, pp. 1076-1086. https://doi.org/10.1016/j.oret.2019.07.011

Management of severe diabetic eye disease: A roundtable
Ho, AC, Avery, RL, Arevalo, JF, Berrocal, MH & Wong, TP 2019, , Retina Today, vol. 2019, no. September, pp. 26-36.

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes
Apolinario, MA, Lampen, SIR, Wong, TP, Henry, CR & Wykoff, CC 2019, , American Journal of Ophthalmology Case Reports, vol. 15, 100492. https://doi.org/10.1016/j.ajoc.2019.100492

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes
TREX-DME Study Group 2019, , American Journal of Ophthalmology, vol. 202, pp. 91-99. https://doi.org/10.1016/j.ajo.2019.02.005

Fovea-sparing rhegmatogenous retinal detachments: impact of clinical factors including time to surgery on visual and anatomic outcomes
Lee, IT, Lampen, SIR, Wong, TP, Major, JC & Wykoff, CC 2019, , Graefes Archive for Clinical and Experimental Ophthalmology, vol. 257, no. 5, pp. 883-889. https://doi.org/10.1007/s00417-018-04236-4

Quarterly anti-vascular endothelial growth factor dosing for neovascular age-related macular degeneration: Real-world clinical outcomes
Rusakevich, AM, Zhou, B, Wong, TP & Wykoff, CC 2019, , Ophthalmic Surgery Lasers and Imaging Retina, vol. 50, no. 9, pp. E250-E256. https://doi.org/10.3928/23258160-20190905-17

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16
AREDS2 Research Group 2018, , Ophthalmology, vol. 125, no. 12, pp. 1913-1928. https://doi.org/10.1016/j.ophtha.2018.05.028

Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial
TREX-AMD Study Group 2018, , American Journal of Ophthalmology, vol. 192, pp. 84-90. https://doi.org/10.1016/j.ajo.2018.05.008

Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications: Secondary outcomes from the SCORE2 randomized clinical trial
SCORE2 Investigator Group 2018, , JAMA Ophthalmology, vol. 136, no. 4, pp. 337-345. https://doi.org/10.1001/jamaophthalmol.2017.6843

Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial
DAVE Study Group 2018, , Ophthalmology, vol. 125, no. 5, pp. 683-690. https://doi.org/10.1016/j.ophtha.2017.11.026